Healthcare Sales & Marketing Network News: chronic obstructive pulmonary disease

Searching News Database: chronic obstructive pulmonary disease

HSMN NewsFeed - 31 Jul 2023
Viatris Announces Launch of Breyna(TM) (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort(R) for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 9 Jan 2023
SoniVie Raises $60m in Round C Financing, and Appoints New Board Members
Devices Venture Capital

HSMN NewsFeed - 3 Nov 2022
Grifols Receives FDA Clearance for Alphaid(TM) At Home, the First Free Service for U.S. Consumers to Determine Their Risk for Alpha-1
Diagnostics FDA

HSMN NewsFeed - 6 Sep 2022
First Randomized Controlled Study with RejuvenAir(R) for Chronic Bronchitis shows Clinically Significant Results
Devices Drug Delivery Interventional

HSMN NewsFeed - 13 Jul 2022
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study
Devices

HSMN NewsFeed - 3 Feb 2022
Third Pole Therapeutics Closes $25M Financing - eNOfit(TM) Wearable Device Now Ready for Clinical Trials
Devices Venture Capital

HSMN NewsFeed - 20 Oct 2021
FDA Expands Approval of Dupixent(R) (dupilumab) to Include Children Aged 6 to 11 Years with Moderate-to-severe Asthma
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Oct 2021
vTv Therapeutics Announces Deepa Prasad as New President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Top-line Results from a Phase 3 Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension
Biopharmaceuticals

HSMN NewsFeed - 22 Jun 2021
Valeo Pharma Announces Commercial Launch of Enerzair(R) Breezhaler(R) and Atectura(R) Breezhaler(R)
Biopharmaceuticals Product Launch

HSMN NewsFeed - 15 Apr 2021
Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
Devices Venture Capital

HSMN NewsFeed - 18 Jan 2021
New Treatment for Severe Emphysema Now Covered Under Highmark Blue Cross Blue Shield
Devices Reimbursement

HSMN NewsFeed - 11 Nov 2020
CSA Medical Announces Enrollment Milestone in a Mechanism of Action Study utilizing the RejuvenAir(R) System for COPD Patients with Chronic Bronchitis
Devices

HSMN NewsFeed - 22 Oct 2020
CSA Medical Announces First Procedure in the SPRAY-CB Pivotal Trial for the Treatment of Chronic Bronchitis
Devices

HSMN NewsFeed - 17 Aug 2020
Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent(R) Diskus(R)
Biopharmaceuticals Drug Delivery Generics Distribution

HSMN NewsFeed - 24 Jul 2020
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Non-CF Patients with Limited Treatment Options
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 19 Jun 2020
Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 25 May 2020
4DMedical's Lung Imaging Technology Receives FDA Clearance as COVID-19 Intensifies Global Focus on Respiratory Health
Diagnostics Radiology FDA

HSMN NewsFeed - 8 Apr 2020
Third Pole Therapeutics Announces Global Commercialization Agreement with Chiesi Group for Its Tankless, Portable Inhaled Nitric Oxide (iNO) Delivery System
Biopharmaceuticals Licensing

HSMN NewsFeed - 27 Jan 2020
Ninety Percent of Patients Can't Use Inhalers Correctly, Digital Inhaler CapMedic Receives FDA Clearance to Change That
Devices Drug Delivery FDA

HSMN NewsFeed - 2 Jan 2020
Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson
Biopharmaceuticals Oncology Drug Delivery Licensing

HSMN NewsFeed - 1 Oct 2019
Lannett Enters Into Distribution Agreement For Generic ADVAIR DISKUS(R)
Biopharmaceuticals Generics Drug Delivery Distribution

HSMN NewsFeed - 16 Sep 2019
Gala Therapeutics Receives FDA Breakthrough Device Designation for the Minimally Invasive RheOx(TM) System for Chronic Bronchitis
Devices FDA

HSMN NewsFeed - 4 Sep 2019
Gala Therapeutics Receives CE Mark for its Minimally Invasive RheOx(TM) System for Chronic Bronchitis
Devices Regulatory

HSMN NewsFeed - 6 Aug 2019
Dupixent(R) (dupilumab) Approved by European Commission for Adolescents with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 16 May 2019
Pulmatrix Announces Leadership Change
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 7 May 2019
Dupixent(R) (dupilumab) Approved for Severe Asthma by European Commission
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Apr 2019
CSL Behring Delivers on its Continued Commitment to Alpha 1 Patients with FDA Approval of Convenient Single-Vial Dosing for ZEMAIRA(R) [Alpha1-Proteinase Inhibitor (Human)]
Biopharmaceuticals FDA Product Launch

HSMN NewsFeed - 3 Apr 2019
CSA Medical, Inc. Receives FDA Breakthrough Device Designation and IDE Approval for its RejuvenAir(R) System for COPD Patients with Chronic Bronchitis
Devices FDA

HSMN NewsFeed - 1 Mar 2019
CHMP Recommends Approval of Dupixent(R) (dupilumab) for Asthma Indication
Biopharmaceuticals Regulatory

HSMN NewsFeed - 12 Feb 2019
U.S. FDA Approves DARZALEX(R) (daratumumab) Split-Dosing Regimen
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 11 Feb 2019
Nuvaira Announces a $79 Million Financing Round to Pursue Groundbreaking Treatment of COPD
Devices Venture Capital Personnel

HSMN NewsFeed - 5 Dec 2018
Olympus Spiration(R) Valve System Is FDA Approved for the Endobronchial Treatment of Emphysema
Devices FDA

HSMN NewsFeed - 22 Oct 2018
FDA Approves Asthma Indication for Dupixent(R) (dupilumab)
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Oct 2018
FDA Approves Stiolto(R) Respimat(R) Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 27 Aug 2018
Janssen Announces Results from MARINER and COMMANDER HF Studies
Biopharmaceuticals Cardiology

HSMN NewsFeed - 8 Aug 2018
Janssen Submits U.S. & EU Regulatory Applications Seeking Approval of DARZALEX(R) (daratumumab) Split Dosing Regimen
Biopharmaceuticals Oncology FDA Regulatory

HSMN NewsFeed - 7 Jun 2018
Henry Schein Medical Launches Its New EasyOne Air Spirometer
Devices Product Launch

HSMN NewsFeed - 16 May 2018
Positive Phase 3 Trial of DUPIXENT(R) (dupilumab) in Adolescents with Inadequately Controlled Moderate-to-severe Atopic Dermatitis
Biopharmaceuticals Dermatology

HSMN NewsFeed - 30 Apr 2018
Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 23 Feb 2018
VoCare Develops the World's First Mobile Professional Grade Medical Multi-Diagnostic Device, Which Provides a Revolutionary Integrated Mobile Point-of-Care Solution as Well as a Remote Patient Monitoring Solution
Devices Monitoring

HSMN NewsFeed - 29 Jan 2018
Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Dec 2017
DARZALEX(R) (daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Nov 2017
ResMed Elects Karen Drexler to its Board of Directors
Devices Personnel

HSMN NewsFeed - 13 Nov 2017
Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Nov 2017
Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 23 Oct 2017
United Therapeutics Announces FDA Approval of Third Generation Nebulizer for the Tyvaso(R) Inhalation System
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 6 Sep 2017
Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Aug 2017
Impax Announces Settlement of Contract Litigation on Opana(R) ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets
Biopharmaceuticals Litigation

HSMN NewsFeed - 20 Jul 2017
Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals

HSMN NewsFeed - 17 May 2017
Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel
Devices Litigation

HSMN NewsFeed - 16 May 2017
Introducing the Softest CPAP Mask from ResMed
Devices Product Launch

HSMN NewsFeed - 26 Apr 2017
Inspirion Delivery Sciences Receives FDA Approval for RoxyBond(TM) (oxycodone hydrochloride) tablets CII, the First and Only Immediate Release Opioid Analgesic with Abuse-Deterrent Label Claims
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 25 Apr 2017
ResMed Unveils AirMini – the World’s Smallest CPAP
Devices Product Launch

HSMN NewsFeed - 12 Jan 2017
ResMed's myAir(TM) Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea
Devices

HSMN NewsFeed - 22 Nov 2016
DARZALEX(R) (daratumumab) Approved by U.S. FDA in Combination with Two Standard of Care Regimens for the Treatment of Patients with Multiple Myeloma Who Have Received At Least One Prior Therapy
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 20 Oct 2016
Propeller Health Completes $21.5 Million Financing to Transform Respiratory Disease through Digitally-Guided Therapy
Devices Venture Capital

HSMN NewsFeed - 5 Oct 2016
Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
Biopharmaceuticals Licensing

HSMN NewsFeed - 27 Sep 2016
Insmed Appoints Roger Adsett as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Sep 2016
CSA Medical Presented Early Clinical Data on the RejuvenAir Metered Cryospray System at the European Respiratory Society (ERS) Conference
Devices

HSMN NewsFeed - 5 Sep 2016
New Data: STIOLTO(R) RESPIMAT(R) (tiotropium bromide+olodaterol) Inhalation Spray Significantly Improved Exercise Capacity in People with COPD
Biopharmaceuticals Devices Drug Delivery

HSMN NewsFeed - 8 Aug 2016
Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2016
Merck Receives CHMP Positive Opinion for KEYTRUDA(R) (pembrolizumab) for the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 21 Jun 2016
Theravance Biopharma Highlights Positive Top-Line Results From Pivotal Phase 3 FULFIL Study of the Closed Triple Announced by GlaxoSmithKline and Innoviva
Biopharmaceuticals

HSMN NewsFeed - 16 Jun 2016
Merck’s KEYTRUDA(R) (pembrolizumab) Demonstrates Superior Progression-Free and Overall Survival Compared to Chemotherapy as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 May 2016
Egalet Settles Patent Litigations with Purdue Pharma
Biopharmaceuticals Litigation

HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Mar 2016
Adamis Pharmaceuticals Announces Agreement to Acquire US Compounding
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Feb 2016
Genentech Provides Update On Two Identical Phase III Studies Of Lebrikizumab In People With Severe Asthma
Biopharmaceuticals

HSMN NewsFeed - 12 Feb 2016
Apellis Completes $47 Million Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Jan 2016
Allakos Successfully Completes Dosing in Phase 1 Clinical Trial of AK001 and Announces Expansion of its Executive Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Dec 2015
Oral REVLIMID(R) Plus Dexamethasone Granted Approval for Treatment of Patients with Newly Diagnosed Multiple Myeloma in Japan
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 8 Dec 2015
Pulmatrix Appoints Mark Iwicki Chairman of the Board
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 1 Oct 2015
Bristol-Myers Squibb Receives Approval from the U.S. Food and Drug Administration for the Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen in BRAF V600 Wild-Type Unresectable or Metastatic Melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 23 Sep 2015
XENiOS(R) Receives Cash Infusion from Existing Investors to Expand Commercial Operations in US and Europe
Devices Venture Capital

HSMN NewsFeed - 15 Sep 2015
Bellerophon Therapeutics Announces Leadership Team Changes
Devices Drug Delivery Personnel

HSMN NewsFeed - 25 Jun 2015
Pulmatrix Appoints William Duke, Jr., as Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 27 Apr 2015
Akorn Announces Recent Executive Appointments
Biopharmaceuticals Generic Personnel

HSMN NewsFeed - 24 Apr 2015
Bristol-Myers Squibb Receives Positive CHMP Opinion in the European Union for Opdivo (nivolumab) for the Treatment of Advanced Melanoma in Both First-Line and Previously Treated Patients
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 16 Oct 2014
FDA Approves Boehringer Ingelheim's OFEV(R) (nintedanib) as First Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Sep 2014
Biota Pharmaceuticals Announces Changes to Management and Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Aug 2014
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Aug 2014
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin
Biopharmaceuticals Endocrinology Drug Delivery Licensing

HSMN NewsFeed - 1 Aug 2014
FDA Approves Boehringer Ingelheim's Striverdi(R) Respimat(R) (olodaterol) Inhalation Spray for Maintenance Treatment of COPD
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Jul 2014
RestorGenex Announces Management Changes
Biopharmaceuticals Dermatology Ophthalmology Personnel

HSMN NewsFeed - 11 Jun 2014
GSK and Theravance Announce Positive Data From Two Studies Evaluating the Efficacy and Safety of Incruse(TM) Ellipta(R) When Added to Relvar(R)/Breo(R) Ellipta(R) in Patients With COPD
Biopharmaceuticals

HSMN NewsFeed - 29 May 2014
Masimo Announces CE Mark of iSpO2(TM) Rx Pulse Oximeter for Mobile Devices
Devices Monitoring Regulatory

HSMN NewsFeed - 29 Apr 2014
Teva Receives European Marketing Authorization for DuoResp Spiromax(R) for the Treatment of Asthma and COPD
Biopharmaceuticals Regulatory

HSMN NewsFeed - 3 Apr 2014
Holaira Closes $42 Million Venture Financing Round
Devices Venture Capital Personnel

HSMN NewsFeed - 14 Mar 2014
GSK and Theravance Announce Positive Results From Studies Comparing ANORO(TM) ELLIPTA(TM) With SERETIDE(R) DISKUS(R) and ADVAIR(R) DISKUS(R) in Patients With COPD
Biopharmaceuticals

HSMN NewsFeed - 21 Feb 2014
Teva Receives CHMP Positive Opinion for DuoResp(R) Spiromax(R) for the Treatment of Patients Diagnosed with Asthma and COPD in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Jan 2014
Cempra, Inc. Names David Moore as Chief Commercial Officer to Manage Commercial Development and Launch of Solithromycin and Taksta(TM)
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Dec 2013
Electromed, Inc. Receives FDA Market Clearance for the SmartVest(R) SQL(TM)
Devices FDA

HSMN NewsFeed - 18 Dec 2013
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 20 Sep 2013
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Sep 2013
ALung Technologies Raises $15.8 Million in Series B-1 Financing
Devices Venture Capital

HSMN NewsFeed - 18 Jul 2013
Celgene Will Discontinue Phase III ORIGIN(R) Trial in Previously Untreated Elderly Patients with B-Cell Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 May 2013
Teva and Alexza Announce Teva’s License to Market ADASUVE(R) in the U.S.
Biopharmaceuticals Licensing

HSMN NewsFeed - 25 Apr 2013
ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment
Devices FDA

HSMN NewsFeed - 3 Apr 2013
Aquinox Pharmaceuticals Completes US $18 million Series C Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 26 Feb 2013
Holaira Bolsters Executive Team
Devices Personnel

HSMN NewsFeed - 26 Feb 2013
Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 25 Feb 2013
First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
Devices

HSMN NewsFeed - 17 Jan 2013
Sanovas Files for FDA Clearance of Vas Zeppelin(TM) Smart Catheter(TM)
Devices Interventional FDA

HSMN NewsFeed - 13 Nov 2012
Pearl Therapeutics Raises $65 Million Series D to Start PT003 Phase 3
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Oct 2012
NICE Approves Pharmaxis' Bronchitol(R) As An Important New Treatment Option For Cystic Fibrosis Patients
Biopharmaceuticals Regulatory

HSMN NewsFeed - 28 Sep 2012
Seebri(R) Inhalation Capsules Receive MHLW Approval as Once-daily Maintenance Treatment for COPD in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Sep 2012
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Sep 2012
Pulmatrix Appoints Robert Clarke, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Sep 2012
Higher dose of Novartis drug Exelon(R) Patch approved by FDA for patients with mild to moderate Alzheimer's disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 30 Aug 2012
Sunovion Pharmaceuticals Inc. to Acquire Elevation Pharmaceuticals, Inc.
Biopharmaceuticals Drug Delivery Mergers & Acquisitions

HSMN NewsFeed - 13 Jul 2012
GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Jul 2012
GSK and Theravance Announce Positive Results From Four Pivotal Phase III Studies for Once-Daily LAMA/LABA (UMEC/VI) in COPD
Biopharmaceuticals

HSMN NewsFeed - 6 Jun 2012
ORENCIA(R) (abatacept) Demonstrates Comparable Efficacy to Humira(R) (adalimumab) in Patients with Moderate to Severe Rheumatoid Arthritis in First Head-to-Head Study of These Agents
Biopharmaceuticals

HSMN NewsFeed - 23 Mar 2012
GSK and Theravance Announce Completion of the Relovair(TM)* Registrational Programme and Topline Results From Relovair(TM) vs. Advair(R) Phase III Studies in COPD
Biopharmaceuticals

HSMN NewsFeed - 20 Jan 2012
Remicade(R) (Infliximab) Receives Positive Opinion From CHMP In Europe for Treatment of Ulcerative Colitis in Pediatric Patients
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 9 Jan 2012
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies for Once-Daily Relovair(TM)* in COPD and Asthma
Biopharmaceuticals

HSMN NewsFeed - 10 Oct 2011
FDA Approves Combivent(R) Respimat(R) (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Sep 2011
Natus Acquires Embla Systems LLC - Leading Sleep Diagnostic Company
Devices Mergers & Acquisitions

HSMN NewsFeed - 26 Aug 2011
NUCYNTA(R) ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Aug 2011
Pulmatrix Invests in Clinical Programs in COPD and Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 21 Jul 2011
Bristol-Myers Squibb to Acquire Amira Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 2 Jun 2011
GSK and Theravance Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD
Biopharmaceuticals

HSMN NewsFeed - 23 May 2011
ResMed Announces Management Reorganization
Devices Personnel

HSMN NewsFeed - 19 May 2011
Takeda to Acquire Nycomed
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Apr 2011
Deep Breeze Introduces Breeze@home(TM) -- A New Telemonitoring Device to Improve COPD Assessment
Devices Monitoring

HSMN NewsFeed - 7 Mar 2011
Breathe Technologies Receives FDA Clearance for Home Use of Portable Ventilator
Devices Personnel FDA

HSMN NewsFeed - 1 Mar 2011
Forest Announces FDA Approval of Daliresp(TM) (Roflumilast) as a Treatment to Reduce the Risk of COPD Exacerbations in Patients with Severe COPD Associated with Chronic Bronchitis and a History of Exacerbations
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Feb 2011
Pearl Therapeutics Appoints Charles (Chuck) Bramlage President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 10 Jan 2011
Optimer Pharmaceuticals Announces Key Additions to Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Nov 2010
New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE(R) After Inadequate Response to Enbrel(R) or Humira(R) Demonstrate Marked Clinical Improvement
Biopharmaceuticals

HSMN NewsFeed - 1 Nov 2010
Steven Kesten, M.D., Leader in Pulmonary Medicine, Joins Uptake Medical as Vice President and Chief Medical Officer
Devices Personnel

HSMN NewsFeed - 19 Oct 2010
Pearl Therapeutics Raises $69 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Oct 2010
FDA Approves Pharmaxis' ARIDOL (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
Biopharmaceuticals Diagnostics FDA

HSMN NewsFeed - 4 Oct 2010
FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research & Development Regarding New Drug Application for Tapentadol Extended Release
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Sep 2010
Deep Breeze Launches Unique, Non-Invasive, Radiation-Free Emergency Department Pulmonary Imaging System in the U.S.
Devices

HSMN NewsFeed - 24 Aug 2010
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA
Biopharmaceuticals Distribution

HSMN NewsFeed - 10 Aug 2010
Environmental Tectonics Corporation's Biomedical Systems Announces the Sale of a BARA-MED(R) Monoplace Hyperbaric Chamber for Placement in Vietnam
Devices Wound Care

HSMN NewsFeed - 7 Jul 2010
Uptake Medical Completes Series B Financing Round for $17.5 Million
Devices Venture Capital

HSMN NewsFeed - 30 Jun 2010
Calistoga Pharmaceuticals Raises $40 Million in Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 Jun 2010
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 19 May 2010
Spiration Announces Positive Results of European Study Evaluating Safety and Effectiveness of Bronchial Valve Treatment for Severe Emphysema
Devices

HSMN NewsFeed - 19 May 2010
STELARA(TM) Significantly Improves Symptoms of Depression, Anxiety and Health-Related Quality of Life in Patients With Moderate to Severe Psoriasis
Biopharmaceuticals Dermatology

HSMN NewsFeed - 26 Apr 2010
Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas(R) in Europe and Canada
Biopharmaceuticals Distribution

HSMN NewsFeed - 15 Apr 2010
REMICADE(R) Study Results Show Greater Steroid-Free Remission and Mucosal Healing Compared With Conventional Immunomodulator Azathioprine in Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 13 Apr 2010
FDA Maintains Essential Use Status of Combivent(R) (ipratropium bromide and albuterol sulfate) Inhalation Aerosol Through 2013
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Apr 2010
Entest Biomedical Announces Intent to Acquire Medistem
Regenerative Medicine Mergers & Acquisitions

HSMN NewsFeed - 7 Apr 2010
Entest BioMedical, Inc. Announces the Addition of New Chief Financial Officer to Management Team
Regenerative Medicine Personnel

HSMN NewsFeed - 4 Mar 2010
Covidien Announces Preferred Vendor Partnership with OSF Healthcare System for Nellcor OxiMax Pulse Oximetry Products
Devices Monitoring Group Purchasing

HSMN NewsFeed - 23 Feb 2010
Environmental Tectonics Corporation Announces Additional Baramed Monoplace Hyperbaric Chamber Sales
Devices Wound Care

HSMN NewsFeed - 2 Feb 2010
Bio-Matrix Scientific Group's Majority Owned Subsidiary Entest BioMedical Initiates Studies to Support Stem Cell / Laser Regenerative Therapy for COPD
Regenerative Medicine

HSMN NewsFeed - 21 Jan 2010
Elevation Pharmaceuticals Raises $30 Million in Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Jan 2010
Forest and Almirall Announce Positive Results from the ACCORD COPD I Phase III Study of aclidinium bromide in Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals

HSMN NewsFeed - 17 Dec 2009
FDA Approves SPIRIVA(R) HandiHaler(R) for the Reduction of COPD Exacerbations
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 7 Dec 2009
Adamis Pharmaceuticals Announces Signing of Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 7 Dec 2009
La Jolla Pharmaceutical Company Announces Signing of Definitive Merger Agreement With Adamis Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Dec 2009
New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Oct 2009
New Data Describe Safety of Subcutaneous Administration of ORENCIA(R) (abatacept) For Patients with Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 13 Oct 2009
Meda Launches Onsolis(TM) (Fentanyl Buccal Soluble Film) for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 3 Sep 2009
Dainippon Sumitomo Pharma to Acquire Sepracor for U.S. $23.00 Per Share in an All-Cash Tender Offer Valued at Approximately U.S. $2.6 Billion
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Aug 2009
Updated ORENCIA(R) (abatacept) Labeling Includes Data to Support Earlier Use in Adult Patients with Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 13 Aug 2009
Covidien Announces Iowa Health System's Conversion to the Nellcor OxiMax Pulse Oximetry System
Devices Monitoring

HSMN NewsFeed - 8 Jun 2009
Medical Acoustics Files Application with FDA for 510(k) Clearance of Therapeutic Lung Flute
Devices

HSMN NewsFeed - 27 May 2009
Covidien Launches Alarm Management System for the Nellcor(TM) OxiMax(TM) N-600x(TM) Pulse Oximeter
Devices Monitoring

HSMN NewsFeed - 21 May 2009
Budesonide/Formoterol Plus Tiotropium Improves the Quality of Life of Patients With Severe COPD
Biopharmaceuticals

HSMN NewsFeed - 19 May 2009
Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
Biopharmaceuticals

HSMN NewsFeed - 4 May 2009
Ironwood Announces Linaclotide European Licensing Agreement with Almirall
Biopharmaceuticals Gastroenterology Licensing

HSMN NewsFeed - 20 Apr 2009
Mpex Pharmaceuticals Names Mark Wiggins Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Apr 2009
Covidien Launches Alarm Management System for the Nellcor OxiMax N-600x Pulse Oximeter
Devices Monitoring

HSMN NewsFeed - 7 Apr 2009
EPIX Pharmaceuticals Announces Sale of U.S., Canadian and Australian Rights for MS-325 (formerly marketed as Vasovist, gadofosveset trisodium, by Bayer Schering Pharma) to Lantheus Medical Imaging, Inc.
Biopharmaceuticals Radiology Acquisitions

HSMN NewsFeed - 25 Feb 2009
Aton Pharma Acquires U.S. TIMOPTIC(R)
Biopharmaceuticals Ophthalmology Acquisitions

HSMN NewsFeed - 10 Feb 2009
Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Jan 2009
Axikin Pharmaceuticals Spins out of Actimis
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 Dec 2008
Osiris Receives Approval for Prochymal Expanded Access Program in Canada
Biopharmaceuticals Regenerative Medicine Regulatory

HSMN NewsFeed - 24 Nov 2008
Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
Biopharmaceuticals

HSMN NewsFeed - 23 Oct 2008
EPIX Pharmaceuticals Announces Reduction in Force
Biopharmaceuticals

HSMN NewsFeed - 1 Oct 2008
Cardica's Anastomosis Systems Enable 'Total Connector' Beating Heart Cardiac Bypass Procedures
Devices Surgery Cardiology

HSMN NewsFeed - 23 Sep 2008
OHSU Announces First Clinical Use in the Pacific Northwest of Novalis Tx(TM) Technology for Non-Invasive, Image-Guided Stereotactic Body Radiation Therapy (SBRT) and Radiosurgery
Devices Oncology

HSMN NewsFeed - 18 Sep 2008
Enbrel(R) Shown to Deliver Long-Lasting Improvements in Psoriasis Patients' Quality of Life
Biopharmaceuticals Dermatology

HSMN NewsFeed - 15 Sep 2008
NicOx announces second naproxcinod pivotal phase 3 study (302) meets efficacy primary endpoints and supports non-detrimental blood pressure effect
Biopharmaceuticals

HSMN NewsFeed - 10 Sep 2008
Ban of CFC in Inhalers Spurs Product Innovation, Market Growth
Devices Drug Delivery

HSMN NewsFeed - 3 Sep 2008
MAP Pharmaceuticals Appoints Alan H. Cohen, M.D., as Vice President, Clinical Development and Medical Affairs, Pulmonary
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Sep 2008
Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals

HSMN NewsFeed - 14 Aug 2008
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Aug 2008
Inhaler Devices are Still a Major Hurdle in Asthma and COPD Treatment
Biopharmaceuticals Devices Drug Delivery

HSMN NewsFeed - 28 Jul 2008
Osiris Therapeutics Appoints Chief Financial Officer
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 24 Jul 2008
Talecris Biotherapeutics Receives Orphan Drug Designation for Aerosolized Form of Alpha1-Antitrypsin (AAT) From the European Commission
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Jul 2008
MAP Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development and Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jul 2008
European Commission Announces Marketing Authorisation for 50mg Once Weekly Enbrel(R) for Patients With Moderate-to-Severe Psoriasis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 13 Jun 2008
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
Biopharmaceuticals

HSMN NewsFeed - 23 May 2008
New Evidence Advocates the use of Enbrel to Combat and Effectively Control the Debilitating Symptoms of Psoriasis
Biopharmaceuticals Dermatology

HSMN NewsFeed - 21 May 2008
Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50
Biopharmaceuticals

HSMN NewsFeed - 1 May 2008
Sepracor and Arrow Sign Global License and Development Agreement Covering Technology to Enhance Ciclesonide and BROVANA(R) Franchises
Biopharmaceuticals Licensing

HSMN NewsFeed - 1 May 2008
Sepracor and Arrow Sign Global License and Development Agreement for XOPENEX(R)/Ipratropium Inhalation Solution Combination
Biopharmaceuticals Licensing

HSMN NewsFeed - 30 Apr 2008
FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Apr 2008
Aradigm Announces Data Showing No Occurrence of Primary Lung Cancer in Patients Treated with AERx(R) Insulin Diabetes Management System (iDMS)
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 8 Apr 2008
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Apr 2008
Advancing Interoperability - Nonin(R) Medical Unveils World's First Bluetooth(R)-Enabled, Wireless Fingertip Pulse Oximeter
Devices Monitoring

HSMN NewsFeed - 26 Mar 2008
Breathe Technologies, Inc. Closes on $15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
Devices Venture Capital

HSMN NewsFeed - 5 Mar 2008
TOPIGEN Pharmaceuticals Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Mar 2008
Draeger's SmartCare(R)/PS Reduces Overall Ventilation Time 33%, Weaning Time up to 40% and ICU Length of Stay to 20%
Devices FDA

HSMN NewsFeed - 21 Feb 2008
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
Biopharmaceuticals

HSMN NewsFeed - 20 Feb 2008
Pfizer to Acquire Encysive Pharmaceuticals
Biopharmacetuicals Mergers & Acquisitions

HSMN NewsFeed - 5 Feb 2008
MAP Pharmaceuticals Announces Resignation of Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jan 2008
Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 16 Jan 2008
Teva Specialty Pharmaceuticals and UCB Announce U.S. Respiratory Collaboration Agreement
Biopharmaceuticals

HSMN NewsFeed - 20 Dec 2007
Hollis-Eden Pharmaceuticals Announces Cystic Fibrosis Foundation Therapeutics Selects TRIOLEX(TM) (HE3286) as a Next-Generation Oral Anti-Inflammatory Drug Candidate
Biopharmaceuticals

HSMN NewsFeed - 18 Dec 2007
Anthera's A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Dec 2007
Anthera Pharmaceuticals Names Christopher P. Lowe Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Dec 2007
Pharmaxis Commences Operations in United States
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Nov 2007
Orexo Announces New Executive Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Nov 2007
Orexo Completes the Acquisition of Biolipox, Appoints New CEO and Publishes a Prospectus
Biopharmaceuticals Mergers & Acquisitions Personnel

HSMN NewsFeed - 14 Nov 2007
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals

HSMN NewsFeed - 12 Nov 2007
Orexo Acquires Biolipox
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 6 Nov 2007
REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide
Biopharmaceuticals

HSMN NewsFeed - 5 Nov 2007
Sepracor Inc. Announces the Establishment of a Unique Product-Specific Billing Code (or J-Code) for BROVANA(R)
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 31 Oct 2007
Allergan, Inc. Receives FDA Approval for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 29 Oct 2007
N30 Pharma Announces License Agreement With NitroMed, Inc.
Biopharmaceuticals Licensing

HSMN NewsFeed - 26 Oct 2007
Orexo to Acquire Biolipox - Update
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 25 Oct 2007
Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium Levels and Well-Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia
Biopharmaceuticals

HSMN NewsFeed - 25 Oct 2007
Aradigm Corporation Reports Initial Human Data on a Novel Approach to Treatment of Tobacco Smoking Addiction Using its AERx Essence(R) Nicotine Inhaler
Devices Drug Delivery

HSMN NewsFeed - 24 Oct 2007
Two Clinical Trials for Nebulized Formoterol Fumarate on Long-Term and Cardiovascular Safety in Treating COPD
Biopharmaceuticals

HSMN NewsFeed - 24 Oct 2007
Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD
Biopharmaceuticals

HSMN NewsFeed - 24 Oct 2007
CoreValve's 18-French ReValving(TM) System for percutaneous aortic valve replacement (PAVR) demonstrated 'live' at TCT 2007
Devices Interventional Cardiology

HSMN NewsFeed - 22 Oct 2007
Deep Breeze Ltd. Launches Unique Non-Invasive, Radiation-Free Pulmonary Imaging System in the U.S.
Devices

HSMN NewsFeed - 22 Oct 2007
Study Using PARI Nebulizer Finds COPD Therapy of Nebulizer and Inhaler Combo More Effective than Inhaler Alone
Devices Drug Delivery

HSMN NewsFeed - 15 Oct 2007
Clinical Studies Show REMICADE Reduces Incidence of Bowel Surgeries in Ulcerative Colitis Patients
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 8 Oct 2007
Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
Biopharmaceuticals

HSMN NewsFeed - 26 Sep 2007
Spiration, Inc. Announces First Patient Enrollment in U.S. Pivotal Trial of Minimally Invasive Treatment for Severe Emphysema
Devices

HSMN NewsFeed - 25 Sep 2007
Critical Therapeutics Highlights Near-Term Milestones to Drive Commercial Success and Clinical Development
Biopharmaceuticals

HSMN NewsFeed - 19 Sep 2007
Spiration Inc. Announces Positive Results from Pilot Study of Treatment for Patients with Severe Emphysema at European Respiratory Society's Annual Congress
Devices

HSMN NewsFeed - 19 Sep 2007
Evotec to Acquire Renovis, Seek NASDAQ Listing
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Sep 2007
New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 11 Sep 2007
Pharmacopeia Announces Senior Additions to Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Sep 2007
Aradigm and CyDex Sign Development Collaboration Agreement
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 15 Aug 2007
TOPIGEN Secures C$26M (US$25M) in Series C Venture Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 9 Aug 2007
FDA Clears Unique Non-Invasive, Radiation-Free Pulmonary Imaging System
Devices FDA

HSMN NewsFeed - 8 Aug 2007
GSK Receives Decision From FDA on Advair(R) 500/50 for COPD
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Jul 2007
FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 28 Jun 2007
Critical Therapeutics and Dey, L.P. Complete Definitive Co-Promotion Agreement for Perforomist(TM) Inhalation Solution
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 15 Jun 2007
REMICADE(R) Two Year Data in Ankylosing Spondylitis Show Improvement in Spinal Mobility and Spinal Inflammation
Biopharmaceuticals

HSMN NewsFeed - 7 Jun 2007
Remicade(R) Receives EU Approval as First and Only Biologic Treatment for Pediatric Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 21 May 2007
Clinical Trial Data for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference
Biopharmaceuticals

HSMN NewsFeed - 11 May 2007
FDA Approves Dey, L.P.'s Perforomist(TM) (Formoterol Fumarate) Inhalation Solution for Maintenance Treatment of COPD
Biopharmaceuticals FDA

HSMN NewsFeed - 1 May 2007
FDA Advisory Committee Finds Substantial Evidence to Support Advair 500/50 in Reducing COPD Exacerbations
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Apr 2007
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 13 Apr 2007
First Patient Enrolled in Phase 2 'PLASMA' Trial With A-002 for Patients With Coronary Atherosclerosis
Biopharmaceuticals Cardiology

HSMN NewsFeed - 11 Apr 2007
BROVANA(TM) Inhalation Solution Now Available by Prescription for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals

HSMN NewsFeed - 10 Apr 2007
TOPIGEN Expands Executive Team With Senior Business Development and Pharmaceutical Development Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Apr 2007
EPIX Provides Update Regarding Status of Vasovist(TM) Appeal
Biopharmaceuticals Radiology FDA

HSMN NewsFeed - 26 Mar 2007
European Union CHMP Recommends Approval of First and Only Biologic Treatment for Pediatric Crohn's Disease: REMICADE(R)
Biopharmaceuticals Regulatory Gastroenterology

HSMN NewsFeed - 20 Mar 2007
MGI PHARMA Announces Positive Results from a Pivotal Phase 3 Study of Aquavan(R) Injection in Patients Undergoing Bronchoscopy
Biopharmaceuticals

HSMN NewsFeed - 20 Mar 2007
Anthera Pharmaceuticals, Inc. Announces Appointment of Dr. James Pennington as Executive Vice President & Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Mar 2007
Critical Therapeutics and DEY, L.P. Enter into Co-Promotion Agreement for Respiratory Care Products
Biopharmaceuticals

HSMN NewsFeed - 8 Mar 2007
Anthera Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board for Respiratory and Acute Care Programs
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Mar 2007
Abbott Canada Launches Oscient Pharmaceuticals' FACTIVE Tablets in Canada
Biopharmacetuicals

HSMN NewsFeed - 28 Feb 2007
EPIX Pharmaceuticals Files Formal Appeal for Vasovist(TM) with the Center for Drug Evaluation and Research
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Feb 2007
Dr. David D. Waters Joins Anthera Pharmaceuticals as Cardiovascular Research Fellow
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Feb 2007
EPIX Pharmaceuticals Presents Data from Novel MRI Imaging Agent at the Society for Cardiovascular Magnetic Resonance Meeting
Biopharmaceuticals Radiology Cardiology

HSMN NewsFeed - 2 Feb 2007
New Analyses Reinforce Efficacy of REMICADE(R) in Treatment of Severe Psoriasis
Biopharmaceuticals Dermatology

HSMN NewsFeed - 2 Feb 2007
REMICADE(R) Therapy Shown to Improve Productivity in Patients Treated for Chronic Plaque Psoriasis
Biopharmaceuticals Dermatology

HSMN NewsFeed - 2 Feb 2007
Veteran Pharmaceutical Executive Joins AerovectRx Corp. Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jan 2007
Anthera Receives IND Approval from FDA to Begin Phase 2 'IMPACTS' Trial With A-001 for Prevention of Acute Chest Syndrome in Patients with Sickle Cell Disease
Biopharmaceuticals

HSMN NewsFeed - 8 Jan 2007
VIASYS Receives FDA Approval to Market Its PulmoLife(TM) Spirometry Screener
Devices FDA

HSMN NewsFeed - 4 Jan 2007
Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
Biopharmaceuticals

HSMN NewsFeed - 4 Jan 2007
Anthera Receives FDA Approval to Begin Phase 2 'PLASMA' Trial With A-002 for Patients With Coronary Atherosclerosis
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 29 Dec 2006
Savient Pharmaceuticals Announces Launch of Authorized Generic of Oxandrin(R) with Watson Pharmaceuticals
Biopharmaceuticals Generics

HSMN NewsFeed - 15 Dec 2006
Critical Therapeutics Announces NIH-Sponsored Study to Investigate the Efficacy Of ZYFLO(R) In Patients with Acute Exacerbations Of COPD
Biopharmaceuticals

HSMN NewsFeed - 14 Dec 2006
EPIX Pharmaceuticals to File Appeal with the Center for Drug Evaluation and Research for Vasovist(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Dec 2006
Cardium's Generx Advances to Phase 3 Following Meeting With FDA
Biopharmaceuticals Cardiology

HSMN NewsFeed - 4 Dec 2006
Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 6 Nov 2006
EPIX Announces Canadian Approval of Vasovist(TM); Marks 30th Country in Which Vasovist is Approved for Marketing
Biopharmaceuticals Regulatory Radiology

HSMN NewsFeed - 6 Nov 2006
Pharmacopeia Announces the Appointment of Vice President, Clinical and Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Oct 2006
Data Show Treatment With Remicade(R) Reduced Hospitalizations for Ulcerative Colitis Patients By Half
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 23 Oct 2006
BROVANA(TM) (Arformoterol Tartrate) Inhalation Solution Study Data Presented at American College of Chest Physicians Annual Conference
Biopharmaceuticals

HSMN NewsFeed - 19 Oct 2006
FDA Expands REMICADE(R) Indication for Ulcerative Colitis: Biologic Maintains Long-Term Clinical Remission and Mucosal Healing
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 13 Oct 2006
Data on FACTIVE(R) Tablets Short-Course Therapy in Patients with Co-Morbidities Presented at Annual Meeting of Infectious Diseases Society of America
Biopharmaceuticals

HSMN NewsFeed - 11 Oct 2006
GSK Submits Supplemental Drug Application for Advair in COPD
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Oct 2006
MIMA Cancer Center Treats Lung Cancer With Image-Guided Body Radiosurgery Using Trilogy(TM) Accelerator From Varian Medical Systems
Devices Oncology

HSMN NewsFeed - 7 Oct 2006
FDA Approves Sepracor's BROVANA(TM) (Arformoterol Tartrate) Inhalation Solution for Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Sep 2006
FDA Approves REMICADE(R) for Treatment of Chronic Severe Plaque Psoriasis: Marks Major Milestone for Patients With High Disease Burden
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Sep 2006
Pharmaxis Board Change
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Sep 2006
EPIX Pharmaceuticals Announces Top-line Results from Phase 3 Trial of PRX-00023 in Generalized Anxiety Disorder
Biopharmaceuticals

HSMN NewsFeed - 20 Sep 2006
EPIX Announces Australian Approval of Vasovist(TM)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 14 Sep 2006
Exubera Effective in Diabetes Patients who Have Respiratory Infections or are Exposed to Passive Cigarette Smoke, New Analyses Show
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 7 Sep 2006
Myogen Initiates Open-Label Phase 3 Clinical Trial of Ambrisentan in Patients with Pulmonary Hypertension
Biopharmaceuticals

HSMN NewsFeed - 6 Sep 2006
Dynavax Establishes Collaboration for TLR-9 Agonists for Asthma and COPD With AstraZeneca
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Sep 2006
Anthera Licenses Portfolio of Anti-Inflammatory Products From Eli Lilly and Company and Shionogi & Co., Ltd.
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Sep 2006
SkyePharma and Mundipharma Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in Europe
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Jul 2006
GSK Announces U.S. Government Purchase of Relenza(R) for State Stockpiles
Biopharmaceuticals

HSMN NewsFeed - 13 Jul 2006
EPIX Pharmaceuticals Retains Full Rights to Fibrin-Binding Imaging Agent EP-2104R as Schering AG Decides Not to Exercise Option for Development Program
Biopharmaceuticals Radiology

HSMN NewsFeed - 30 Jun 2006
EPIX Pharmaceuticals Files Appeal with FDA Regarding Vasovist(TM) Approvable Letters
Biopharmaceuticals Radiology FDA

HSMN NewsFeed - 22 Jun 2006
Sosei Business Strategy Update and Portfolio Review
Biopharmaceuticals

HSMN NewsFeed - 24 May 2006
New Analysis Showed Ulcerative Colitis Patients in Clinical Remission Had Higher Rates of Employment and Lower Rates of Disability
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 24 May 2006
Predix Pharmaceuticals Achieves Full Enrollment for Phase III Clinical Trial of PRX-00023 in Generalized Anxiety Disorder
Biopharmaceuticals

HSMN NewsFeed - 8 May 2006
Uptake Medical Corp. Closes $9 Million in Series A Financing
Devices Venture Capital

HSMN NewsFeed - 8 May 2006
Kos and SkyePharma Sign Exclusive License Agreement for the Marketing and Distribution of Flutiform(TM) in the United States
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 8 May 2006
SkyePharma and Kos Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in the United States
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 5 May 2006
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) Supplemental Biologics License Application (sBLA) for Third-Party Manufacturing Facility Lonza Biologics Inc.
Biopharmaceuticals FDA

HSMN NewsFeed - 4 May 2006
Aerovance Secures $60 Million in Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 May 2006
Pharmacopeia Announces Management Changes
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 136

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 136 additional stories matching:
chronic obstructive pulmonary disease
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.